Dysentery - 64 Studies Found Not yet recruiting : Shigella Sonnei 53G Challenge : Healthy : 2016-06-24 : Biological: Shigella sonnei 53G Completed : A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults : Shigella Sonnei Infection : 2016-02-01 : Biological: S. sonnei vaccine 25 μg Active, not recruiting : Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a : Shigellosis : 2015-12-23 : Biological: Flexyn2a 2 doses o Completed : Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a : Shigellosis : 2015-02-23 : Biological: Flexyn2a Intramusc Completed : Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults : Shigellosis : 2014-01-02 : Biological: S. sonnei 1790GAHB Completed : Study of Nitazoxanide in the Treatment of Amebiasis in Children : Amebiasis : 2006-08-18 : Drug: Nitazoxanide Completed : Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents : Amebiasis : 2006-08-18 : Drug: Nitazoxanide Completed : Field Studies of Amebiasis in Bangladesh : Amebiasis Cryptosporidium : 2016-03-22 Completed : Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population : Helminthiasis Amoebiasis : 2015-03-05 : Drug: Mebendazole Mebendazole Completed : Auranofin PK Following Oral Dose Administration : Amoebiasis : 2014-03-13 : Drug: Auranofin Auranofin is a gold-containing chemical salt available as 3mg capsules. Cohort 1 receive <<< Previous | Next >>>